Results 61 to 70 of about 11,054 (202)
A Clinical Study of Diabetic Retinopathy
A clinical study of diabetic retinopathy was conducted from March- May 2002 to diagnose a patient’s diabetic retinopathy level and identify eyes of proliferative diabetic retinopathy and maculopathy so that these patients could get appropriate and timely
KJD Karki
doaj +1 more source
Advancing Treatment of Degenerative Eye Diseases at the Nanoscale
Nanotherapeutics possess the potential to overcome longstanding bottlenecks in treating degenerative ophthalmic diseases. With a highly tunable surface chemistry, nanotechnology platforms can be customized to navigate specific anatomical barriers in the eye and target pathways of diseases.
Li Yao Jin +5 more
wiley +1 more source
Purpose: To determine the effect of panretinal photocoagulation on optic disk topographic parameters in non-glaucomatous patients with proliferative diabetic retinopathy. Methods: This was a prospective, single-center, observational study.
Breno Marques da Silva Azevedo (6675785) +6 more
core +2 more sources
Background Proliferative diabetic retinopathy (PDR) characterized by neovascularization of the optic disk, retina, and/or iris may be an aberrant attempt to alleviate hypoxia in eyes with severe capillary closure or other retinal ischemia.
Mohammed S Ahmed
doaj +1 more source
ABSTRACT Background Postoperative complications substantially increase morbidity, mortality and healthcare costs. Understanding prognostic factors is essential for risk stratification, targeted prevention strategies, and development of prediction models.
Anders Peder Højer Karlsen +15 more
wiley +1 more source
Box plot representation of the perifoveal vessel tortuosity results in the five study groups.
No DR: No diabetic retinopathy, NPDR: Non-proliferative diabetic retinopathy, PDR: Proliferative diabetic retinopathy, PRP: Panretinal photocoagulation, PDR+PRP: Proliferative diabetic retinopathy receiving panretinal photocoagulation ...
Alaa E. Fayed (6703916) +3 more
core +1 more source
Targeted biological agents targeting VEGF, integrin, dopamine D2 receptor, ROCK, and BCL‐XL have entered the clinical trial phase and deserve particular attention. The treatment paradigm has shifted toward personalized and precision medicine, positioning optimized SML as a promising adjunctive therapy.
Xinying Hu +7 more
wiley +1 more source
Purpose: To evaluate contrast sensitivity in non-high-risk, treatment-naïve proliferative diabetic retinopathy patients treated with panretinal photocoagulation and intravitreal injections of ranibizumab) versus panretinal photocoagulation alone ...
Robert Hutnik (12436669) +10 more
core +1 more source
A novel navigated laser system brings new efficacy to the treatment of retinovascular disorders
The laser photocoagulation is now treatment of choice for various retinovascular disorders. Conventional slit-lamp based laser delivery systems have many limitations including, questionable accuracy, need of contact lens with local anesthesia, and ...
Jay Chhablani +3 more
doaj +1 more source
Combining oral sodium‐glucose cotransporter 2 inhibitors with reduced intravitreal injections of anti‐vascular endothelial growth factor showed potential efficacy for mild diabetic macular edema. ABSTRACT Aims To investigate the potential of sodium–glucose cotransporter 2 inhibitors (SGLT2i) as a less invasive treatment option for mild diabetic macular
Yoko Takatsuna +6 more
wiley +1 more source

